WuXi AppTec Co., Ltd.
WuXi AppTec Co., Ltd. WUXAY Peers
See (WUXAY) competitors and their performances in Stock Market.
Peer Comparison Table: Medical - Diagnostics & Research Industry
Detailed financial metrics including price, market cap, P/E ratio, and more.
| Symbol | Price | Change % | Market Cap | P/E Ratio | EPS | Dividend Yield |
|---|---|---|---|---|---|---|
| WUXAY | $8.74 | -1.91% | 24.2B | 16.19 | $0.54 | +0.74% |
| LZAGY | $69.29 | +1.75% | 50B | 63.57 | $1.09 | +0.74% |
| LZAGF | $689.88 | -2.51% | 48.5B | 63.52 | $10.86 | +0.42% |
| WUXIF | $7.34 | N/A | 21B | 13.59 | $0.54 | +2.54% |
| BMXMF | $134.25 | +1.18% | 15.8B | 32.43 | $4.14 | +0.69% |
| ERFSF | $66.99 | +4.62% | 11.8B | 28.15 | $2.38 | +1.60% |
| SKHCF | $18.10 | N/A | 8.7B | 24.79 | $0.73 | +3.88% |
| SKHHY | $17.21 | +0.76% | 8.3B | 23.26 | $0.74 | +3.92% |
| DSRLF | $92.31 | -15.31% | 5B | 23.43 | $3.94 | +1.47% |
| HNGZY | $4.00 | N/A | 4.5B | 26.67 | $0.15 | +1.99% |
Stock Comparison
WUXAY vs LZAGY Comparison
WUXAY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, WUXAY stands at 24.2B. In comparison, LZAGY has a market cap of 50B. Regarding current trading prices, WUXAY is priced at $8.74, while LZAGY trades at $69.29.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
WUXAY currently has a P/E ratio of 16.19, whereas LZAGY's P/E ratio is 63.57. In terms of profitability, WUXAY's ROE is +0.19%, compared to LZAGY's ROE of +0.06%. Regarding short-term risk, WUXAY is more volatile compared to LZAGY. This indicates potentially higher risk in terms of short-term price fluctuations for WUXAY.
WUXAY vs LZAGF Comparison
WUXAY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, WUXAY stands at 24.2B. In comparison, LZAGF has a market cap of 48.5B. Regarding current trading prices, WUXAY is priced at $8.74, while LZAGF trades at $689.88.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
WUXAY currently has a P/E ratio of 16.19, whereas LZAGF's P/E ratio is 63.52. In terms of profitability, WUXAY's ROE is +0.19%, compared to LZAGF's ROE of +0.06%. Regarding short-term risk, WUXAY is more volatile compared to LZAGF. This indicates potentially higher risk in terms of short-term price fluctuations for WUXAY.
WUXAY vs WUXIF Comparison
WUXAY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, WUXAY stands at 24.2B. In comparison, WUXIF has a market cap of 21B. Regarding current trading prices, WUXAY is priced at $8.74, while WUXIF trades at $7.34.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
WUXAY currently has a P/E ratio of 16.19, whereas WUXIF's P/E ratio is 13.59. In terms of profitability, WUXAY's ROE is +0.19%, compared to WUXIF's ROE of +0.19%. Regarding short-term risk, WUXAY is more volatile compared to WUXIF. This indicates potentially higher risk in terms of short-term price fluctuations for WUXAY.
WUXAY vs BMXMF Comparison
WUXAY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, WUXAY stands at 24.2B. In comparison, BMXMF has a market cap of 15.8B. Regarding current trading prices, WUXAY is priced at $8.74, while BMXMF trades at $134.25.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
WUXAY currently has a P/E ratio of 16.19, whereas BMXMF's P/E ratio is 32.43. In terms of profitability, WUXAY's ROE is +0.19%, compared to BMXMF's ROE of +0.10%. Regarding short-term risk, WUXAY is more volatile compared to BMXMF. This indicates potentially higher risk in terms of short-term price fluctuations for WUXAY.
WUXAY vs ERFSF Comparison
WUXAY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, WUXAY stands at 24.2B. In comparison, ERFSF has a market cap of 11.8B. Regarding current trading prices, WUXAY is priced at $8.74, while ERFSF trades at $66.99.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
WUXAY currently has a P/E ratio of 16.19, whereas ERFSF's P/E ratio is 28.15. In terms of profitability, WUXAY's ROE is +0.19%, compared to ERFSF's ROE of +0.07%. Regarding short-term risk, WUXAY is less volatile compared to ERFSF. This indicates potentially lower risk in terms of short-term price fluctuations for WUXAY.
WUXAY vs SKHCF Comparison
WUXAY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, WUXAY stands at 24.2B. In comparison, SKHCF has a market cap of 8.7B. Regarding current trading prices, WUXAY is priced at $8.74, while SKHCF trades at $18.10.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
WUXAY currently has a P/E ratio of 16.19, whereas SKHCF's P/E ratio is 24.79. In terms of profitability, WUXAY's ROE is +0.19%, compared to SKHCF's ROE of +0.05%. Regarding short-term risk, WUXAY is more volatile compared to SKHCF. This indicates potentially higher risk in terms of short-term price fluctuations for WUXAY.
WUXAY vs SKHHY Comparison
WUXAY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, WUXAY stands at 24.2B. In comparison, SKHHY has a market cap of 8.3B. Regarding current trading prices, WUXAY is priced at $8.74, while SKHHY trades at $17.21.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
WUXAY currently has a P/E ratio of 16.19, whereas SKHHY's P/E ratio is 23.26. In terms of profitability, WUXAY's ROE is +0.19%, compared to SKHHY's ROE of +0.07%. Regarding short-term risk, WUXAY is more volatile compared to SKHHY. This indicates potentially higher risk in terms of short-term price fluctuations for WUXAY.
WUXAY vs DSRLF Comparison
WUXAY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, WUXAY stands at 24.2B. In comparison, DSRLF has a market cap of 5B. Regarding current trading prices, WUXAY is priced at $8.74, while DSRLF trades at $92.31.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
WUXAY currently has a P/E ratio of 16.19, whereas DSRLF's P/E ratio is 23.43. In terms of profitability, WUXAY's ROE is +0.19%, compared to DSRLF's ROE of +0.09%. Regarding short-term risk, WUXAY is less volatile compared to DSRLF. This indicates potentially lower risk in terms of short-term price fluctuations for WUXAY.
WUXAY vs HNGZY Comparison
WUXAY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, WUXAY stands at 24.2B. In comparison, HNGZY has a market cap of 4.5B. Regarding current trading prices, WUXAY is priced at $8.74, while HNGZY trades at $4.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
WUXAY currently has a P/E ratio of 16.19, whereas HNGZY's P/E ratio is 26.67. In terms of profitability, WUXAY's ROE is +0.19%, compared to HNGZY's ROE of +0.02%. Regarding short-term risk, WUXAY is less volatile compared to HNGZY. This indicates potentially lower risk in terms of short-term price fluctuations for WUXAY.
WUXAY vs VIMGF Comparison
WUXAY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, WUXAY stands at 24.2B. In comparison, VIMGF has a market cap of 1.8B. Regarding current trading prices, WUXAY is priced at $8.74, while VIMGF trades at $3.50.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
WUXAY currently has a P/E ratio of 16.19, whereas VIMGF's P/E ratio is 70.00. In terms of profitability, WUXAY's ROE is +0.19%, compared to VIMGF's ROE of +0.03%. Regarding short-term risk, WUXAY is more volatile compared to VIMGF. This indicates potentially higher risk in terms of short-term price fluctuations for WUXAY.
WUXAY vs MRCHF Comparison
WUXAY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, WUXAY stands at 24.2B. In comparison, MRCHF has a market cap of 1.2B. Regarding current trading prices, WUXAY is priced at $8.74, while MRCHF trades at $21.52.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
WUXAY currently has a P/E ratio of 16.19, whereas MRCHF's P/E ratio is 63.29. In terms of profitability, WUXAY's ROE is +0.19%, compared to MRCHF's ROE of -0.04%. Regarding short-term risk, WUXAY is more volatile compared to MRCHF. This indicates potentially higher risk in terms of short-term price fluctuations for WUXAY.
WUXAY vs IMMVF Comparison
WUXAY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, WUXAY stands at 24.2B. In comparison, IMMVF has a market cap of 918.2M. Regarding current trading prices, WUXAY is priced at $8.74, while IMMVF trades at $3.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
WUXAY currently has a P/E ratio of 16.19, whereas IMMVF's P/E ratio is -13.04. In terms of profitability, WUXAY's ROE is +0.19%, compared to IMMVF's ROE of -2.69%. Regarding short-term risk, WUXAY is less volatile compared to IMMVF. This indicates potentially lower risk in terms of short-term price fluctuations for WUXAY.
WUXAY vs THOXF Comparison
WUXAY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, WUXAY stands at 24.2B. In comparison, THOXF has a market cap of 341M. Regarding current trading prices, WUXAY is priced at $8.74, while THOXF trades at $0.75.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
WUXAY currently has a P/E ratio of 16.19, whereas THOXF's P/E ratio is -37.50. In terms of profitability, WUXAY's ROE is +0.19%, compared to THOXF's ROE of -0.91%. Regarding short-term risk, WUXAY is less volatile compared to THOXF. This indicates potentially lower risk in terms of short-term price fluctuations for WUXAY.
WUXAY vs EDTXF Comparison
WUXAY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, WUXAY stands at 24.2B. In comparison, EDTXF has a market cap of 175.7M. Regarding current trading prices, WUXAY is priced at $8.74, while EDTXF trades at $0.62.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
WUXAY currently has a P/E ratio of 16.19, whereas EDTXF's P/E ratio is -10.27. In terms of profitability, WUXAY's ROE is +0.19%, compared to EDTXF's ROE of +0.79%. Regarding short-term risk, WUXAY is more volatile compared to EDTXF. This indicates potentially higher risk in terms of short-term price fluctuations for WUXAY.
WUXAY vs AMCY Comparison
WUXAY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, WUXAY stands at 24.2B. In comparison, AMCY has a market cap of 171.3M. Regarding current trading prices, WUXAY is priced at $8.74, while AMCY trades at $3.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
WUXAY currently has a P/E ratio of 16.19, whereas AMCY's P/E ratio is N/A. In terms of profitability, WUXAY's ROE is +0.19%, compared to AMCY's ROE of N/A. Regarding short-term risk, WUXAY is more volatile compared to AMCY. This indicates potentially higher risk in terms of short-term price fluctuations for WUXAY.
WUXAY vs IDGXF Comparison
WUXAY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, WUXAY stands at 24.2B. In comparison, IDGXF has a market cap of 164.5M. Regarding current trading prices, WUXAY is priced at $8.74, while IDGXF trades at $0.28.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
WUXAY currently has a P/E ratio of 16.19, whereas IDGXF's P/E ratio is 7.07. In terms of profitability, WUXAY's ROE is +0.19%, compared to IDGXF's ROE of +0.24%. Regarding short-term risk, WUXAY is more volatile compared to IDGXF. This indicates potentially higher risk in terms of short-term price fluctuations for WUXAY.
WUXAY vs NNGRF Comparison
WUXAY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, WUXAY stands at 24.2B. In comparison, NNGRF has a market cap of 164.3M. Regarding current trading prices, WUXAY is priced at $8.74, while NNGRF trades at $12.76.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
WUXAY currently has a P/E ratio of 16.19, whereas NNGRF's P/E ratio is 60.75. In terms of profitability, WUXAY's ROE is +0.19%, compared to NNGRF's ROE of -0.07%. Regarding short-term risk, WUXAY is more volatile compared to NNGRF. This indicates potentially higher risk in terms of short-term price fluctuations for WUXAY.
WUXAY vs ATLN Comparison
WUXAY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, WUXAY stands at 24.2B. In comparison, ATLN has a market cap of 157M. Regarding current trading prices, WUXAY is priced at $8.74, while ATLN trades at $2.69.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
WUXAY currently has a P/E ratio of 16.19, whereas ATLN's P/E ratio is -0.73. In terms of profitability, WUXAY's ROE is +0.19%, compared to ATLN's ROE of -19.68%. Regarding short-term risk, WUXAY is less volatile compared to ATLN. This indicates potentially lower risk in terms of short-term price fluctuations for WUXAY.
WUXAY vs CORBF Comparison
WUXAY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, WUXAY stands at 24.2B. In comparison, CORBF has a market cap of 133.9M. Regarding current trading prices, WUXAY is priced at $8.74, while CORBF trades at $1.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
WUXAY currently has a P/E ratio of 16.19, whereas CORBF's P/E ratio is 3.03. In terms of profitability, WUXAY's ROE is +0.19%, compared to CORBF's ROE of +0.11%. Regarding short-term risk, WUXAY is more volatile compared to CORBF. This indicates potentially higher risk in terms of short-term price fluctuations for WUXAY.
WUXAY vs DIUXF Comparison
WUXAY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, WUXAY stands at 24.2B. In comparison, DIUXF has a market cap of 115.5M. Regarding current trading prices, WUXAY is priced at $8.74, while DIUXF trades at $1.37.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
WUXAY currently has a P/E ratio of 16.19, whereas DIUXF's P/E ratio is 136.72. In terms of profitability, WUXAY's ROE is +0.19%, compared to DIUXF's ROE of -0.07%. Regarding short-term risk, WUXAY is more volatile compared to DIUXF. This indicates potentially higher risk in terms of short-term price fluctuations for WUXAY.
WUXAY vs ANPCF Comparison
WUXAY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, WUXAY stands at 24.2B. In comparison, ANPCF has a market cap of 100M. Regarding current trading prices, WUXAY is priced at $8.74, while ANPCF trades at $0.31.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
WUXAY currently has a P/E ratio of 16.19, whereas ANPCF's P/E ratio is -3.10. In terms of profitability, WUXAY's ROE is +0.19%, compared to ANPCF's ROE of -0.54%. Regarding short-term risk, WUXAY is less volatile compared to ANPCF. This indicates potentially lower risk in terms of short-term price fluctuations for WUXAY.
WUXAY vs TIHE Comparison
WUXAY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, WUXAY stands at 24.2B. In comparison, TIHE has a market cap of 71.9M. Regarding current trading prices, WUXAY is priced at $8.74, while TIHE trades at $1.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
WUXAY currently has a P/E ratio of 16.19, whereas TIHE's P/E ratio is 0.32. In terms of profitability, WUXAY's ROE is +0.19%, compared to TIHE's ROE of +0.01%. Regarding short-term risk, WUXAY is more volatile compared to TIHE. This indicates potentially higher risk in terms of short-term price fluctuations for WUXAY.
WUXAY vs BIOGF Comparison
WUXAY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, WUXAY stands at 24.2B. In comparison, BIOGF has a market cap of 65.4M. Regarding current trading prices, WUXAY is priced at $8.74, while BIOGF trades at $0.66.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
WUXAY currently has a P/E ratio of 16.19, whereas BIOGF's P/E ratio is -0.67. In terms of profitability, WUXAY's ROE is +0.19%, compared to BIOGF's ROE of +2.04%. Regarding short-term risk, WUXAY is more volatile compared to BIOGF. This indicates potentially higher risk in terms of short-term price fluctuations for WUXAY.
WUXAY vs PFGTF Comparison
WUXAY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, WUXAY stands at 24.2B. In comparison, PFGTF has a market cap of 65M. Regarding current trading prices, WUXAY is priced at $8.74, while PFGTF trades at $0.08.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
WUXAY currently has a P/E ratio of 16.19, whereas PFGTF's P/E ratio is -4.00. In terms of profitability, WUXAY's ROE is +0.19%, compared to PFGTF's ROE of -0.41%. Regarding short-term risk, WUXAY is more volatile compared to PFGTF. This indicates potentially higher risk in terms of short-term price fluctuations for WUXAY.
WUXAY vs PCNEF Comparison
WUXAY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, WUXAY stands at 24.2B. In comparison, PCNEF has a market cap of 62M. Regarding current trading prices, WUXAY is priced at $8.74, while PCNEF trades at $2.28.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
WUXAY currently has a P/E ratio of 16.19, whereas PCNEF's P/E ratio is -8.44. In terms of profitability, WUXAY's ROE is +0.19%, compared to PCNEF's ROE of -0.21%. Regarding short-term risk, WUXAY is more volatile compared to PCNEF. This indicates potentially higher risk in terms of short-term price fluctuations for WUXAY.
WUXAY vs SZLSF Comparison
WUXAY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, WUXAY stands at 24.2B. In comparison, SZLSF has a market cap of 59.5M. Regarding current trading prices, WUXAY is priced at $8.74, while SZLSF trades at $0.05.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
WUXAY currently has a P/E ratio of 16.19, whereas SZLSF's P/E ratio is -0.42. In terms of profitability, WUXAY's ROE is +0.19%, compared to SZLSF's ROE of +0.13%. Regarding short-term risk, WUXAY is more volatile compared to SZLSF. This indicates potentially higher risk in terms of short-term price fluctuations for WUXAY.
WUXAY vs CLIFF Comparison
WUXAY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, WUXAY stands at 24.2B. In comparison, CLIFF has a market cap of 44.1M. Regarding current trading prices, WUXAY is priced at $8.74, while CLIFF trades at $0.17.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
WUXAY currently has a P/E ratio of 16.19, whereas CLIFF's P/E ratio is -2.87. In terms of profitability, WUXAY's ROE is +0.19%, compared to CLIFF's ROE of -0.08%. Regarding short-term risk, WUXAY is more volatile compared to CLIFF. This indicates potentially higher risk in terms of short-term price fluctuations for WUXAY.
WUXAY vs BIOQ Comparison
WUXAY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, WUXAY stands at 24.2B. In comparison, BIOQ has a market cap of 40.2M. Regarding current trading prices, WUXAY is priced at $8.74, while BIOQ trades at $45.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
WUXAY currently has a P/E ratio of 16.19, whereas BIOQ's P/E ratio is 15.85. In terms of profitability, WUXAY's ROE is +0.19%, compared to BIOQ's ROE of -0.06%. Regarding short-term risk, WUXAY is more volatile compared to BIOQ. This indicates potentially higher risk in terms of short-term price fluctuations for WUXAY.
WUXAY vs ANPCY Comparison
WUXAY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, WUXAY stands at 24.2B. In comparison, ANPCY has a market cap of 36.1M. Regarding current trading prices, WUXAY is priced at $8.74, while ANPCY trades at $1.12.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
WUXAY currently has a P/E ratio of 16.19, whereas ANPCY's P/E ratio is -1.72. In terms of profitability, WUXAY's ROE is +0.19%, compared to ANPCY's ROE of -0.75%. Regarding short-term risk, WUXAY is more volatile compared to ANPCY. This indicates potentially higher risk in terms of short-term price fluctuations for WUXAY.
WUXAY vs SNANF Comparison
WUXAY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, WUXAY stands at 24.2B. In comparison, SNANF has a market cap of 29.4M. Regarding current trading prices, WUXAY is priced at $8.74, while SNANF trades at $0.27.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
WUXAY currently has a P/E ratio of 16.19, whereas SNANF's P/E ratio is -13.58. In terms of profitability, WUXAY's ROE is +0.19%, compared to SNANF's ROE of -2.51%. Regarding short-term risk, WUXAY is more volatile compared to SNANF. This indicates potentially higher risk in terms of short-term price fluctuations for WUXAY.
WUXAY vs PCHM Comparison
WUXAY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, WUXAY stands at 24.2B. In comparison, PCHM has a market cap of 20.8M. Regarding current trading prices, WUXAY is priced at $8.74, while PCHM trades at $3.55.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
WUXAY currently has a P/E ratio of 16.19, whereas PCHM's P/E ratio is -0.02. In terms of profitability, WUXAY's ROE is +0.19%, compared to PCHM's ROE of +0.53%. Regarding short-term risk, WUXAY is more volatile compared to PCHM. This indicates potentially higher risk in terms of short-term price fluctuations for WUXAY.
WUXAY vs VILGF Comparison
WUXAY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, WUXAY stands at 24.2B. In comparison, VILGF has a market cap of 20.7M. Regarding current trading prices, WUXAY is priced at $8.74, while VILGF trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
WUXAY currently has a P/E ratio of 16.19, whereas VILGF's P/E ratio is -0.30. In terms of profitability, WUXAY's ROE is +0.19%, compared to VILGF's ROE of N/A. Regarding short-term risk, WUXAY is more volatile compared to VILGF. This indicates potentially higher risk in terms of short-term price fluctuations for WUXAY.
WUXAY vs BMKDF Comparison
WUXAY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, WUXAY stands at 24.2B. In comparison, BMKDF has a market cap of 19.1M. Regarding current trading prices, WUXAY is priced at $8.74, while BMKDF trades at $0.21.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
WUXAY currently has a P/E ratio of 16.19, whereas BMKDF's P/E ratio is -21.00. In terms of profitability, WUXAY's ROE is +0.19%, compared to BMKDF's ROE of +2.24%. Regarding short-term risk, WUXAY is more volatile compared to BMKDF. This indicates potentially higher risk in terms of short-term price fluctuations for WUXAY.
WUXAY vs MBGNF Comparison
WUXAY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, WUXAY stands at 24.2B. In comparison, MBGNF has a market cap of 17.3M. Regarding current trading prices, WUXAY is priced at $8.74, while MBGNF trades at $1.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
WUXAY currently has a P/E ratio of 16.19, whereas MBGNF's P/E ratio is -100.00. In terms of profitability, WUXAY's ROE is +0.19%, compared to MBGNF's ROE of +0.37%. Regarding short-term risk, WUXAY is less volatile compared to MBGNF. This indicates potentially lower risk in terms of short-term price fluctuations for WUXAY.
WUXAY vs PMSNF Comparison
WUXAY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, WUXAY stands at 24.2B. In comparison, PMSNF has a market cap of 14.8M. Regarding current trading prices, WUXAY is priced at $8.74, while PMSNF trades at $0.05.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
WUXAY currently has a P/E ratio of 16.19, whereas PMSNF's P/E ratio is -2.50. In terms of profitability, WUXAY's ROE is +0.19%, compared to PMSNF's ROE of +0.69%. Regarding short-term risk, WUXAY is more volatile compared to PMSNF. This indicates potentially higher risk in terms of short-term price fluctuations for WUXAY.
WUXAY vs LDXHF Comparison
WUXAY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, WUXAY stands at 24.2B. In comparison, LDXHF has a market cap of 14.2M. Regarding current trading prices, WUXAY is priced at $8.74, while LDXHF trades at $0.02.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
WUXAY currently has a P/E ratio of 16.19, whereas LDXHF's P/E ratio is -1.90. In terms of profitability, WUXAY's ROE is +0.19%, compared to LDXHF's ROE of -1.38%. Regarding short-term risk, WUXAY is less volatile compared to LDXHF. This indicates potentially lower risk in terms of short-term price fluctuations for WUXAY.
WUXAY vs ABDXF Comparison
WUXAY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, WUXAY stands at 24.2B. In comparison, ABDXF has a market cap of 13.6M. Regarding current trading prices, WUXAY is priced at $8.74, while ABDXF trades at $0.07.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
WUXAY currently has a P/E ratio of 16.19, whereas ABDXF's P/E ratio is -1.40. In terms of profitability, WUXAY's ROE is +0.19%, compared to ABDXF's ROE of -0.63%. Regarding short-term risk, WUXAY is more volatile compared to ABDXF. This indicates potentially higher risk in terms of short-term price fluctuations for WUXAY.
WUXAY vs JMPHF Comparison
WUXAY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, WUXAY stands at 24.2B. In comparison, JMPHF has a market cap of 13.3M. Regarding current trading prices, WUXAY is priced at $8.74, while JMPHF trades at $0.06.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
WUXAY currently has a P/E ratio of 16.19, whereas JMPHF's P/E ratio is -2.91. In terms of profitability, WUXAY's ROE is +0.19%, compared to JMPHF's ROE of -0.11%. Regarding short-term risk, WUXAY is more volatile compared to JMPHF. This indicates potentially higher risk in terms of short-term price fluctuations for WUXAY.
WUXAY vs IZOZF Comparison
WUXAY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, WUXAY stands at 24.2B. In comparison, IZOZF has a market cap of 12.7M. Regarding current trading prices, WUXAY is priced at $8.74, while IZOZF trades at $0.21.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
WUXAY currently has a P/E ratio of 16.19, whereas IZOZF's P/E ratio is -7.00. In terms of profitability, WUXAY's ROE is +0.19%, compared to IZOZF's ROE of +0.47%. Regarding short-term risk, WUXAY is more volatile compared to IZOZF. This indicates potentially higher risk in terms of short-term price fluctuations for WUXAY.
WUXAY vs MXDHF Comparison
WUXAY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, WUXAY stands at 24.2B. In comparison, MXDHF has a market cap of 8.6M. Regarding current trading prices, WUXAY is priced at $8.74, while MXDHF trades at $0.25.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
WUXAY currently has a P/E ratio of 16.19, whereas MXDHF's P/E ratio is -0.12. In terms of profitability, WUXAY's ROE is +0.19%, compared to MXDHF's ROE of -6.91%. Regarding short-term risk, WUXAY is more volatile compared to MXDHF. This indicates potentially higher risk in terms of short-term price fluctuations for WUXAY.
WUXAY vs VRCDF Comparison
WUXAY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, WUXAY stands at 24.2B. In comparison, VRCDF has a market cap of 7.3M. Regarding current trading prices, WUXAY is priced at $8.74, while VRCDF trades at $0.03.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
WUXAY currently has a P/E ratio of 16.19, whereas VRCDF's P/E ratio is -1.00. In terms of profitability, WUXAY's ROE is +0.19%, compared to VRCDF's ROE of -0.73%. Regarding short-term risk, WUXAY is less volatile compared to VRCDF. This indicates potentially lower risk in terms of short-term price fluctuations for WUXAY.
WUXAY vs SQIDF Comparison
WUXAY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, WUXAY stands at 24.2B. In comparison, SQIDF has a market cap of 6.1M. Regarding current trading prices, WUXAY is priced at $8.74, while SQIDF trades at $0.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
WUXAY currently has a P/E ratio of 16.19, whereas SQIDF's P/E ratio is -0.37. In terms of profitability, WUXAY's ROE is +0.19%, compared to SQIDF's ROE of +4.47%. Regarding short-term risk, WUXAY is less volatile compared to SQIDF. This indicates potentially lower risk in terms of short-term price fluctuations for WUXAY.
WUXAY vs IBXXF Comparison
WUXAY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, WUXAY stands at 24.2B. In comparison, IBXXF has a market cap of 4.8M. Regarding current trading prices, WUXAY is priced at $8.74, while IBXXF trades at $0.02.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
WUXAY currently has a P/E ratio of 16.19, whereas IBXXF's P/E ratio is -0.80. In terms of profitability, WUXAY's ROE is +0.19%, compared to IBXXF's ROE of +0.55%. Regarding short-term risk, WUXAY is less volatile compared to IBXXF. This indicates potentially lower risk in terms of short-term price fluctuations for WUXAY.
WUXAY vs AVCRF Comparison
WUXAY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, WUXAY stands at 24.2B. In comparison, AVCRF has a market cap of 4.6M. Regarding current trading prices, WUXAY is priced at $8.74, while AVCRF trades at $0.05.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
WUXAY currently has a P/E ratio of 16.19, whereas AVCRF's P/E ratio is -4.50. In terms of profitability, WUXAY's ROE is +0.19%, compared to AVCRF's ROE of +0.05%. Regarding short-term risk, WUXAY is more volatile compared to AVCRF. This indicates potentially higher risk in terms of short-term price fluctuations for WUXAY.
WUXAY vs TDSGF Comparison
WUXAY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, WUXAY stands at 24.2B. In comparison, TDSGF has a market cap of 4.3M. Regarding current trading prices, WUXAY is priced at $8.74, while TDSGF trades at $0.04.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
WUXAY currently has a P/E ratio of 16.19, whereas TDSGF's P/E ratio is -1.45. In terms of profitability, WUXAY's ROE is +0.19%, compared to TDSGF's ROE of -3.19%. Regarding short-term risk, WUXAY is less volatile compared to TDSGF. This indicates potentially lower risk in terms of short-term price fluctuations for WUXAY.
WUXAY vs RNVA Comparison
WUXAY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, WUXAY stands at 24.2B. In comparison, RNVA has a market cap of 4.3M. Regarding current trading prices, WUXAY is priced at $8.74, while RNVA trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
WUXAY currently has a P/E ratio of 16.19, whereas RNVA's P/E ratio is N/A. In terms of profitability, WUXAY's ROE is +0.19%, compared to RNVA's ROE of +0.23%. Regarding short-term risk, WUXAY is more volatile compared to RNVA. This indicates potentially higher risk in terms of short-term price fluctuations for WUXAY.
WUXAY vs SLDX Comparison
WUXAY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, WUXAY stands at 24.2B. In comparison, SLDX has a market cap of 4.2M. Regarding current trading prices, WUXAY is priced at $8.74, while SLDX trades at $0.04.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
WUXAY currently has a P/E ratio of 16.19, whereas SLDX's P/E ratio is -0.01. In terms of profitability, WUXAY's ROE is +0.19%, compared to SLDX's ROE of +0.06%. Regarding short-term risk, WUXAY is more volatile compared to SLDX. This indicates potentially higher risk in terms of short-term price fluctuations for WUXAY.
WUXAY vs GNTLF Comparison
WUXAY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, WUXAY stands at 24.2B. In comparison, GNTLF has a market cap of 3.7M. Regarding current trading prices, WUXAY is priced at $8.74, while GNTLF trades at $1.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
WUXAY currently has a P/E ratio of 16.19, whereas GNTLF's P/E ratio is -16.67. In terms of profitability, WUXAY's ROE is +0.19%, compared to GNTLF's ROE of -3.62%. Regarding short-term risk, WUXAY is more volatile compared to GNTLF. This indicates potentially higher risk in terms of short-term price fluctuations for WUXAY.
WUXAY vs ICBU Comparison
WUXAY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, WUXAY stands at 24.2B. In comparison, ICBU has a market cap of 3.5M. Regarding current trading prices, WUXAY is priced at $8.74, while ICBU trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
WUXAY currently has a P/E ratio of 16.19, whereas ICBU's P/E ratio is N/A. In terms of profitability, WUXAY's ROE is +0.19%, compared to ICBU's ROE of +0.70%. Regarding short-term risk, WUXAY is less volatile compared to ICBU. This indicates potentially lower risk in terms of short-term price fluctuations for WUXAY.
WUXAY vs IDXG Comparison
WUXAY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, WUXAY stands at 24.2B. In comparison, IDXG has a market cap of 3.5M. Regarding current trading prices, WUXAY is priced at $8.74, while IDXG trades at $0.78.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
WUXAY currently has a P/E ratio of 16.19, whereas IDXG's P/E ratio is 2.79. In terms of profitability, WUXAY's ROE is +0.19%, compared to IDXG's ROE of -1.19%. Regarding short-term risk, WUXAY is more volatile compared to IDXG. This indicates potentially higher risk in terms of short-term price fluctuations for WUXAY.
WUXAY vs NSTM Comparison
WUXAY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, WUXAY stands at 24.2B. In comparison, NSTM has a market cap of 1.8M. Regarding current trading prices, WUXAY is priced at $8.74, while NSTM trades at $0.04.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
WUXAY currently has a P/E ratio of 16.19, whereas NSTM's P/E ratio is -0.63. In terms of profitability, WUXAY's ROE is +0.19%, compared to NSTM's ROE of +0.87%. Regarding short-term risk, WUXAY is less volatile compared to NSTM. This indicates potentially lower risk in terms of short-term price fluctuations for WUXAY.
WUXAY vs IVRO Comparison
WUXAY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, WUXAY stands at 24.2B. In comparison, IVRO has a market cap of 1.4M. Regarding current trading prices, WUXAY is priced at $8.74, while IVRO trades at $0.06.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
WUXAY currently has a P/E ratio of 16.19, whereas IVRO's P/E ratio is -0.75. In terms of profitability, WUXAY's ROE is +0.19%, compared to IVRO's ROE of +0.08%. Regarding short-term risk, WUXAY is less volatile compared to IVRO. This indicates potentially lower risk in terms of short-term price fluctuations for WUXAY.
WUXAY vs IDTA Comparison
WUXAY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, WUXAY stands at 24.2B. In comparison, IDTA has a market cap of 1.3M. Regarding current trading prices, WUXAY is priced at $8.74, while IDTA trades at $0.31.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
WUXAY currently has a P/E ratio of 16.19, whereas IDTA's P/E ratio is 3.10. In terms of profitability, WUXAY's ROE is +0.19%, compared to IDTA's ROE of +0.36%. Regarding short-term risk, WUXAY is more volatile compared to IDTA. This indicates potentially higher risk in terms of short-term price fluctuations for WUXAY.
WUXAY vs DIGP Comparison
WUXAY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, WUXAY stands at 24.2B. In comparison, DIGP has a market cap of 1.1M. Regarding current trading prices, WUXAY is priced at $8.74, while DIGP trades at $0.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
WUXAY currently has a P/E ratio of 16.19, whereas DIGP's P/E ratio is -1.04. In terms of profitability, WUXAY's ROE is +0.19%, compared to DIGP's ROE of +3.08%. Regarding short-term risk, WUXAY is less volatile compared to DIGP. This indicates potentially lower risk in terms of short-term price fluctuations for WUXAY.
WUXAY vs SCRSF Comparison
WUXAY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, WUXAY stands at 24.2B. In comparison, SCRSF has a market cap of 895.7K. Regarding current trading prices, WUXAY is priced at $8.74, while SCRSF trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
WUXAY currently has a P/E ratio of 16.19, whereas SCRSF's P/E ratio is -0.09. In terms of profitability, WUXAY's ROE is +0.19%, compared to SCRSF's ROE of +2.91%. Regarding short-term risk, WUXAY is more volatile compared to SCRSF. This indicates potentially higher risk in terms of short-term price fluctuations for WUXAY.
WUXAY vs EPGNF Comparison
WUXAY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, WUXAY stands at 24.2B. In comparison, EPGNF has a market cap of 692.4K. Regarding current trading prices, WUXAY is priced at $8.74, while EPGNF trades at $0.79.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
WUXAY currently has a P/E ratio of 16.19, whereas EPGNF's P/E ratio is -0.04. In terms of profitability, WUXAY's ROE is +0.19%, compared to EPGNF's ROE of -4.14%. Regarding short-term risk, WUXAY is more volatile compared to EPGNF. This indicates potentially higher risk in terms of short-term price fluctuations for WUXAY.
WUXAY vs TOMDF Comparison
WUXAY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, WUXAY stands at 24.2B. In comparison, TOMDF has a market cap of 140.8K. Regarding current trading prices, WUXAY is priced at $8.74, while TOMDF trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
WUXAY currently has a P/E ratio of 16.19, whereas TOMDF's P/E ratio is N/A. In terms of profitability, WUXAY's ROE is +0.19%, compared to TOMDF's ROE of +0.84%. Regarding short-term risk, WUXAY is less volatile compared to TOMDF. This indicates potentially lower risk in terms of short-term price fluctuations for WUXAY.
WUXAY vs NVTAQ Comparison
WUXAY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, WUXAY stands at 24.2B. In comparison, NVTAQ has a market cap of 85.9K. Regarding current trading prices, WUXAY is priced at $8.74, while NVTAQ trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
WUXAY currently has a P/E ratio of 16.19, whereas NVTAQ's P/E ratio is -0.00. In terms of profitability, WUXAY's ROE is +0.19%, compared to NVTAQ's ROE of +0.00%. Regarding short-term risk, WUXAY is less volatile compared to NVTAQ. This indicates potentially lower risk in terms of short-term price fluctuations for WUXAY.
WUXAY vs ARYC Comparison
WUXAY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, WUXAY stands at 24.2B. In comparison, ARYC has a market cap of 79.3K. Regarding current trading prices, WUXAY is priced at $8.74, while ARYC trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
WUXAY currently has a P/E ratio of 16.19, whereas ARYC's P/E ratio is N/A. In terms of profitability, WUXAY's ROE is +0.19%, compared to ARYC's ROE of +0.55%. Regarding short-term risk, WUXAY is less volatile compared to ARYC. This indicates potentially lower risk in terms of short-term price fluctuations for WUXAY.
WUXAY vs HCLC Comparison
WUXAY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, WUXAY stands at 24.2B. In comparison, HCLC has a market cap of 74K. Regarding current trading prices, WUXAY is priced at $8.74, while HCLC trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
WUXAY currently has a P/E ratio of 16.19, whereas HCLC's P/E ratio is N/A. In terms of profitability, WUXAY's ROE is +0.19%, compared to HCLC's ROE of +0.11%. Regarding short-term risk, WUXAY is more volatile compared to HCLC. This indicates potentially higher risk in terms of short-term price fluctuations for WUXAY.
WUXAY vs OPGX Comparison
WUXAY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, WUXAY stands at 24.2B. In comparison, OPGX has a market cap of 55K. Regarding current trading prices, WUXAY is priced at $8.74, while OPGX trades at $1.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
WUXAY currently has a P/E ratio of 16.19, whereas OPGX's P/E ratio is -0.17. In terms of profitability, WUXAY's ROE is +0.19%, compared to OPGX's ROE of +0.46%. Regarding short-term risk, WUXAY is less volatile compared to OPGX. This indicates potentially lower risk in terms of short-term price fluctuations for WUXAY.
WUXAY vs MEDVF Comparison
WUXAY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, WUXAY stands at 24.2B. In comparison, MEDVF has a market cap of 54K. Regarding current trading prices, WUXAY is priced at $8.74, while MEDVF trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
WUXAY currently has a P/E ratio of 16.19, whereas MEDVF's P/E ratio is -0.03. In terms of profitability, WUXAY's ROE is +0.19%, compared to MEDVF's ROE of +0.57%. Regarding short-term risk, WUXAY is more volatile compared to MEDVF. This indicates potentially higher risk in terms of short-term price fluctuations for WUXAY.
WUXAY vs CHHL Comparison
WUXAY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, WUXAY stands at 24.2B. In comparison, CHHL has a market cap of 37.3K. Regarding current trading prices, WUXAY is priced at $8.74, while CHHL trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
WUXAY currently has a P/E ratio of 16.19, whereas CHHL's P/E ratio is N/A. In terms of profitability, WUXAY's ROE is +0.19%, compared to CHHL's ROE of +0.00%. Regarding short-term risk, WUXAY is less volatile compared to CHHL. This indicates potentially lower risk in terms of short-term price fluctuations for WUXAY.
WUXAY vs MEDD Comparison
WUXAY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, WUXAY stands at 24.2B. In comparison, MEDD has a market cap of 31.9K. Regarding current trading prices, WUXAY is priced at $8.74, while MEDD trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
WUXAY currently has a P/E ratio of 16.19, whereas MEDD's P/E ratio is -0.01. In terms of profitability, WUXAY's ROE is +0.19%, compared to MEDD's ROE of +0.74%. Regarding short-term risk, WUXAY is more volatile compared to MEDD. This indicates potentially higher risk in terms of short-term price fluctuations for WUXAY.
WUXAY vs IHTI Comparison
WUXAY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, WUXAY stands at 24.2B. In comparison, IHTI has a market cap of 28.5K. Regarding current trading prices, WUXAY is priced at $8.74, while IHTI trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
WUXAY currently has a P/E ratio of 16.19, whereas IHTI's P/E ratio is N/A. In terms of profitability, WUXAY's ROE is +0.19%, compared to IHTI's ROE of +0.00%. Regarding short-term risk, WUXAY is less volatile compared to IHTI. This indicates potentially lower risk in terms of short-term price fluctuations for WUXAY.
WUXAY vs CGNH Comparison
WUXAY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, WUXAY stands at 24.2B. In comparison, CGNH has a market cap of 12K. Regarding current trading prices, WUXAY is priced at $8.74, while CGNH trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
WUXAY currently has a P/E ratio of 16.19, whereas CGNH's P/E ratio is N/A. In terms of profitability, WUXAY's ROE is +0.19%, compared to CGNH's ROE of +1.41%. Regarding short-term risk, WUXAY is more volatile compared to CGNH. This indicates potentially higher risk in terms of short-term price fluctuations for WUXAY.
WUXAY vs RSHN Comparison
WUXAY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, WUXAY stands at 24.2B. In comparison, RSHN has a market cap of 8.2K. Regarding current trading prices, WUXAY is priced at $8.74, while RSHN trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
WUXAY currently has a P/E ratio of 16.19, whereas RSHN's P/E ratio is N/A. In terms of profitability, WUXAY's ROE is +0.19%, compared to RSHN's ROE of -5.42%. Regarding short-term risk, WUXAY is more volatile compared to RSHN. This indicates potentially higher risk in terms of short-term price fluctuations for WUXAY.
WUXAY vs ABMC Comparison
WUXAY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, WUXAY stands at 24.2B. In comparison, ABMC has a market cap of 4.8K. Regarding current trading prices, WUXAY is priced at $8.74, while ABMC trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
WUXAY currently has a P/E ratio of 16.19, whereas ABMC's P/E ratio is 0.01. In terms of profitability, WUXAY's ROE is +0.19%, compared to ABMC's ROE of +0.86%. Regarding short-term risk, WUXAY is more volatile compared to ABMC. This indicates potentially higher risk in terms of short-term price fluctuations for WUXAY.
WUXAY vs CYPS Comparison
WUXAY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, WUXAY stands at 24.2B. In comparison, CYPS has a market cap of 4.1K. Regarding current trading prices, WUXAY is priced at $8.74, while CYPS trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
WUXAY currently has a P/E ratio of 16.19, whereas CYPS's P/E ratio is N/A. In terms of profitability, WUXAY's ROE is +0.19%, compared to CYPS's ROE of N/A. Regarding short-term risk, WUXAY is less volatile compared to CYPS. This indicates potentially lower risk in terms of short-term price fluctuations for WUXAY.
WUXAY vs GWHP Comparison
WUXAY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, WUXAY stands at 24.2B. In comparison, GWHP has a market cap of 1.3K. Regarding current trading prices, WUXAY is priced at $8.74, while GWHP trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
WUXAY currently has a P/E ratio of 16.19, whereas GWHP's P/E ratio is -0.00. In terms of profitability, WUXAY's ROE is +0.19%, compared to GWHP's ROE of +0.00%. Regarding short-term risk, WUXAY is less volatile compared to GWHP. This indicates potentially lower risk in terms of short-term price fluctuations for WUXAY.
WUXAY vs ROSGQ Comparison
WUXAY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, WUXAY stands at 24.2B. In comparison, ROSGQ has a market cap of 593. Regarding current trading prices, WUXAY is priced at $8.74, while ROSGQ trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
WUXAY currently has a P/E ratio of 16.19, whereas ROSGQ's P/E ratio is N/A. In terms of profitability, WUXAY's ROE is +0.19%, compared to ROSGQ's ROE of -1.35%. Regarding short-term risk, WUXAY is more volatile compared to ROSGQ. This indicates potentially higher risk in terms of short-term price fluctuations for WUXAY.
WUXAY vs BIOCQ Comparison
WUXAY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, WUXAY stands at 24.2B. In comparison, BIOCQ has a market cap of 263. Regarding current trading prices, WUXAY is priced at $8.74, while BIOCQ trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
WUXAY currently has a P/E ratio of 16.19, whereas BIOCQ's P/E ratio is -0.00. In terms of profitability, WUXAY's ROE is +0.19%, compared to BIOCQ's ROE of -1.38%. Regarding short-term risk, WUXAY is more volatile compared to BIOCQ. This indicates potentially higher risk in terms of short-term price fluctuations for WUXAY.
WUXAY vs HTGMQ Comparison
WUXAY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, WUXAY stands at 24.2B. In comparison, HTGMQ has a market cap of 221. Regarding current trading prices, WUXAY is priced at $8.74, while HTGMQ trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
WUXAY currently has a P/E ratio of 16.19, whereas HTGMQ's P/E ratio is N/A. In terms of profitability, WUXAY's ROE is +0.19%, compared to HTGMQ's ROE of -2.73%. Regarding short-term risk, WUXAY is more volatile compared to HTGMQ. This indicates potentially higher risk in terms of short-term price fluctuations for WUXAY.
WUXAY vs RGDXQ Comparison
WUXAY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, WUXAY stands at 24.2B. In comparison, RGDXQ has a market cap of 39. Regarding current trading prices, WUXAY is priced at $8.74, while RGDXQ trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
WUXAY currently has a P/E ratio of 16.19, whereas RGDXQ's P/E ratio is N/A. In terms of profitability, WUXAY's ROE is +0.19%, compared to RGDXQ's ROE of -1.27%. Regarding short-term risk, WUXAY is more volatile compared to RGDXQ. This indicates potentially higher risk in terms of short-term price fluctuations for WUXAY.
WUXAY vs DMTKQ Comparison
WUXAY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, WUXAY stands at 24.2B. In comparison, DMTKQ has a market cap of 35. Regarding current trading prices, WUXAY is priced at $8.74, while DMTKQ trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
WUXAY currently has a P/E ratio of 16.19, whereas DMTKQ's P/E ratio is N/A. In terms of profitability, WUXAY's ROE is +0.19%, compared to DMTKQ's ROE of -0.80%. Regarding short-term risk, WUXAY is more volatile compared to DMTKQ. This indicates potentially higher risk in terms of short-term price fluctuations for WUXAY.
WUXAY vs MRPS Comparison
WUXAY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, WUXAY stands at 24.2B. In comparison, MRPS has a market cap of 0. Regarding current trading prices, WUXAY is priced at $8.74, while MRPS trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
WUXAY currently has a P/E ratio of 16.19, whereas MRPS's P/E ratio is N/A. In terms of profitability, WUXAY's ROE is +0.19%, compared to MRPS's ROE of N/A. Regarding short-term risk, WUXAY is more volatile compared to MRPS. This indicates potentially higher risk in terms of short-term price fluctuations for WUXAY.
WUXAY vs AGHC Comparison
WUXAY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, WUXAY stands at 24.2B. In comparison, AGHC has a market cap of 0. Regarding current trading prices, WUXAY is priced at $8.74, while AGHC trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
WUXAY currently has a P/E ratio of 16.19, whereas AGHC's P/E ratio is N/A. In terms of profitability, WUXAY's ROE is +0.19%, compared to AGHC's ROE of +2.90%. Regarding short-term risk, WUXAY is more volatile compared to AGHC. This indicates potentially higher risk in terms of short-term price fluctuations for WUXAY.
WUXAY vs EPGNY Comparison
WUXAY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, WUXAY stands at 24.2B. In comparison, EPGNY has a market cap of 0. Regarding current trading prices, WUXAY is priced at $8.74, while EPGNY trades at $2.39.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
WUXAY currently has a P/E ratio of 16.19, whereas EPGNY's P/E ratio is -1.60. In terms of profitability, WUXAY's ROE is +0.19%, compared to EPGNY's ROE of -0.19%. Regarding short-term risk, WUXAY is more volatile compared to EPGNY. This indicates potentially higher risk in terms of short-term price fluctuations for WUXAY.
WUXAY vs BGNX Comparison
WUXAY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, WUXAY stands at 24.2B. In comparison, BGNX has a market cap of 0. Regarding current trading prices, WUXAY is priced at $8.74, while BGNX trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
WUXAY currently has a P/E ratio of 16.19, whereas BGNX's P/E ratio is N/A. In terms of profitability, WUXAY's ROE is +0.19%, compared to BGNX's ROE of N/A. Regarding short-term risk, WUXAY is more volatile compared to BGNX. This indicates potentially higher risk in terms of short-term price fluctuations for WUXAY.